U.S.  Implements New Export Controls to Address National Security Risks Related to Biotechnology
| | | | | | | | | | | | |

U.S. Implements New Export Controls to Address National Security Risks Related to Biotechnology

On Jan. 15, 2025, the U.S. Department of Commerce’s Bureau of Industry and Security (BIS) released an Interim…

BiVACOR Total Artificial Heart Successfully Implanted in Five Patients as Part of FDA Early Feasibility Study; FDA Greenlights Expansion of the EFS
| | | | | |

BiVACOR Total Artificial Heart Successfully Implanted in Five Patients as Part of FDA Early Feasibility Study; FDA Greenlights Expansion of the EFS

On Dec. 18, 2024, BiVACOR, a clinical-stage medical device company, announced the successful completion of the first phase…

Strengthening the U.S. Biomedical Research Enterprise Entails National Strategic Coordination, Focus on Health Equity
| | | | | | | | | |

Strengthening the U.S. Biomedical Research Enterprise Entails National Strategic Coordination, Focus on Health Equity

On Oct. 1, 2024, the National Academy of Medicine (NAM) announced a study showing that although the U.S….